Dynamic expression of tenascin-C after myocardial ischemia and reperfusion: Assessment by125i-anti-tenascin-c antibody imaging

Journal of Nuclear Medicine

Volumn 51, Issue 7, 2010, Pages 1116-1122

  Taki, Junichi ^a   Inaki, Anri ^a   Wakabayashi, Hiroshi ^a   Imanaka Yoshida, Kyoko ^b   Ogawa, Kazuma ^c   Hiroe, Michiaki ^d   Shiba, Kazuhiro ^c   Yoshida, Toshimichi ^b   Kinuya, Seigo ^a,c  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b MIE UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

125I anti tenascin C antibody; Autoradiography; Myocardial ischemia; Reperfusion; Tenascin C

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TENASCIN; TENASCIN C ANTIBODY I 125; UNCLASSIFIED DRUG; 2 METHOXYISOBUTYLISONITRILE; 2-METHOXYISOBUTYLISONITRILE; DIAGNOSTIC AGENT; NITRILE; RADIOACTIVE IODINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG UPTAKE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEFT CORONARY ARTERY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; HEART; HEART MUSCLE; IMMUNOLOGY; ISOTOPE LABELING; METABOLISM; PATHOLOGY; REPERFUSION INJURY; SCINTISCANNING; STATISTICAL ANALYSIS; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; AUTORADIOGRAPHY; DATA INTERPRETATION, STATISTICAL; HEART; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; ISOTOPE LABELING; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRILES; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TECHNETIUM TC 99M SESTAMIBI; TENASCIN; TISSUE DISTRIBUTION;

EID: 77954966987     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.071340     Document Type: Article

References (22)

1. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.
2. Chung CY, Murphy-Ullrich JE, Erickson HP. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol Biol Cell. 1996;7:883-892.
3. Jones FS, Jones PL. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn. 2000;218:235-259.
4. Willems IE, Arends JW, Daemen MJ. Tenascin and fibronectin expression in healing human myocardial scars. J Pathol. 1996;179:321-325.
5. Imanaka-Yoshida K, Hiroe M, Nishikawa T, et al. Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction. Lab Invest. 2001;81:1015-1024.
6. Imanaka-Yoshida K, Hiroe M, Yasutomi Y, et al. Tenascin-C is a useful marker for disease activity in myocarditis. J Pathol. 2002;197:388-394.
7. Frangogiannis NG, Shimoni S, Chang SM, et al. Active interstitial remodeling: an important process in the hibernating human myocardium. J Am Coll Cardiol. 2002;39:1468-1474. (Pubitemid 34439062)
8. Morimoto S, Imanaka-Yoshida K, Hiramitsu S, et al. Diagnostic utility of tenascin-C for evaluation of the activity of human acute myocarditis. J Pathol. 2005;205:460-467.
9. 111In monoclonal antibody specific for tenascin-C. Circulation. 2002;106:1397-1402.
10. Tamura A, Kusachi S, Nogami K, et al. Tenascin expression in endomyocardial biopsy specimens in patients with dilated cardiomyopathy: distribution along margin of fibrotic lesions. Heart. 1996;75:291-294. (Pubitemid 26094968)
11. Tsukada B, Terasaki F, Shimomura H, et al. High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: expression of tenascin C as a possible marker for inflammation. Hum Pathol. 2009;40:1015-1022.
12. Hessel MH, Bleeker GB, Bax JJ, et al. Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels. Eur J Heart Fail. 2007;9:1058-1063.
13. Milting H, Ellinghaus P, Seewald M, et al. Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices. J Heart Lung Transplant. 2008;27:589-596.
14. Terasaki F, Okamoto H, Onishi K, et al.; Study Group for Intractable Diseases by a Grant from the Ministry of Health, Labor and Welfare of Japan. Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy. Circ J. 2007;71:327-330.
15. Fujimoto N, Onishi K, Sato A, et al. Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure. J Card Fail. 2009;15:898-905.
16. Sato A, Aonuma K, Imanaka-Yoshida K, et al. Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. J Am Coll Cardiol. 2006;47:2319-2325.
17. Odaka K, Uehara T, Arano Y, et al. Noninvasive detection of cardiac repair after acute myocardial infarction in rats by 111 In Fab fragment of monoclonal antibody specific for tenascin-C. Int Heart J. 2008;49:481-492.
18. 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment. J Nucl Med. 2007;48:1301-1307.
19. Wilbur DS, Hadley SW, Grant LM, Hylarides MD. Radioiodinated iodobenzoyl conjugates of a monoclonal antibody Fab fragment: in vivo comparisons with chloramine-T-labeled Fab. Bioconjug Chem. 1991;2:111-116.
20. Kalembeyi I, Inada H, Nishiura R, Imanaka-Yoshida K, Sakakura T, Yoshida T. Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1. Int J Cancer. 2003;105:53-60.
21. Nishiura R, Noda N, Minoura H, et al. Expression of matrix metalloproteinase-3 in mouse endometrial stromal cells during early pregnancy: regulation by interleukin-1alpha and tenascin-C. Gynecol Endocrinol. 2005;21:111-118.
22. Tamaoki M, Imanaka-Yoshida K, Yokoyama K, et al. Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol. 2005;167:71-80.